Array
(
[id] => 527
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/527.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients aged 45–65 years without signs,
symptoms, or history of CVD, ECG and
biomarkers should be considered before high-risk
NCS. (Evidence: Level C，Recommendation: Class Ⅱa)
[laiyuan] => 在没有心血管疾病体征、症状或病史的45-65岁患者中，应在高危NCS术前考虑完善心电图和生物标志物检查。（证据级别：Level C ；推荐强度：Class Ⅱa）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在没有心血管疾病体征、症状或病史的45-65岁患者中，应在高危NCS术前考虑完善心电图和生物标志物检查。（证据级别：Level C ；推荐强度：Class Ⅱa）
In patients aged 45–65 years without signs,
symptoms, or history of CVD, ECG and
biomarkers should be considered before high-risk
NCS. (Evidence: Level C，Recommendation: Class Ⅱa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 528
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/528.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur and
symptoms or signs of CVD, TTE is recommended
before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 在新检测到到杂音的患者中并存在心血管疾病的症状或体征，建议在NCS之前使用经胸超声心动图评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在新检测到到杂音的患者中并存在心血管疾病的症状或体征，建议在NCS之前使用经胸超声心动图评估。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with a newly detected murmur and
symptoms or signs of CVD, TTE is recommended
before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 529
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/529.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur suggesting clinically significant pathology, TTE is recommended before high-risk NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 在新检测到提示有临床意义病理性杂音的患者，推荐在高风险NCS术前检查超声心动图。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在新检测到提示有临床意义病理性杂音的患者，推荐在高风险NCS术前检查超声心动图。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with a newly detected murmur suggesting clinically significant pathology, TTE is recommended before high-risk NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 530
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/530.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with a newly detected murmur, but without other signs or symptoms of CVD, TTE should be considered before moderate-risk NCS. (Evidence: Level C，Recommendation: Class Ⅱa)
[laiyuan] => 在新检测到杂音的患者中，但如果没有其他心血管疾病体征或症状，在中度风险NCS之前应考虑经胸超声心电图。
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在新检测到杂音的患者中，但如果没有其他心血管疾病体征或症状，在中度风险NCS之前应考虑经胸超声心电图。
In patients with a newly detected murmur, but without other signs or symptoms of CVD, TTE should be considered before moderate-risk NCS. (Evidence: Level C，Recommendation: Class Ⅱa)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 531
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/531.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended to measure haemoglobin pre-operatively in patients scheduled for intermediate- to high-risk NCS. (Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 推荐择期行中高危NCS的患者术前测量血红蛋白。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐择期行中高危NCS的患者术前测量血红蛋白。（证据级别：Level B ；推荐强度：Class Ⅰ）
It is recommended to measure haemoglobin pre-operatively in patients scheduled for intermediate- to high-risk NCS. (Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 532
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/532.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => It is recommended to perform a pre-operative risk assessment, ideally at the same time as the NCS is proposed. (Evidence: Level B，Recommendation: Class Ⅰ)
[laiyuan] => 推荐进行术前风险评估，最好与NCS同时进行。（证据级别：Level B ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐进行术前风险评估，最好与NCS同时进行。（证据级别：Level B ；推荐强度：Class Ⅰ）
It is recommended to perform a pre-operative risk assessment, ideally at the same time as the NCS is proposed. (Evidence: Level B，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 533
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/533.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In all patients scheduled for NCS, an accurate
history and clinical examination are recommended. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 建议在所有计划接受NCS的患者中，准确询问病史，并完善临床检查。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在所有计划接受NCS的患者中，准确询问病史，并完善临床检查。（证据级别：Level C ；推荐强度：Class Ⅰ）
In all patients scheduled for NCS, an accurate
history and clinical examination are recommended. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 534
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/534.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with dyspnoea and/or peripheral oedema, an ECG and an NT-proBNP/BNP test is indicated before NCS, unless there is a certain non-cardiac explanation.(Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 对于呼吸困难和（或）外周水肿的患者，在非心脏手术之前需要进行心电图和NT-proBNP/BNP检测，除非可被特定的非心脏原因所解释。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于呼吸困难和（或）外周水肿的患者，在非心脏手术之前需要进行心电图和NT-proBNP/BNP检测，除非可被特定的非心脏原因所解释。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with dyspnoea and/or peripheral oedema, an ECG and an NT-proBNP/BNP test is indicated before NCS, unless there is a certain non-cardiac explanation.(Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 535
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/535.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients with dyspnoea and/or peripheral oedema and elevated NT-proBNP/BNP, TTE is recommended before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 对于有呼吸困难和/或外周水肿且 NT-proBNP/BNP 升高的患者，推荐非心脏手术前进行经胸超声心动图。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于有呼吸困难和/或外周水肿且 NT-proBNP/BNP 升高的患者，推荐非心脏手术前进行经胸超声心动图。（证据级别：Level C ；推荐强度：Class Ⅰ）
In patients with dyspnoea and/or peripheral oedema and elevated NT-proBNP/BNP, TTE is recommended before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
Array
(
[id] => 536
[catid] => 191
[title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/536.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:13:01
[updatetime] => 2024-01-11 15:13:01
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => LOE
[zjfj] =>
[tjqd] =>
[nianfen] => 2022
[guojia] => European Society of Cardiology
[pdf] =>
[tjyjyw] =>
[lyyw] => If time allows, it is recommended to optimize guideline-recommended treatment of CVD and CV risk factors before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
[laiyuan] => 如果时间允许，推荐在非心脏手术前优化指南推荐的心血管疾病治疗和心血管危险因素控制。（证据级别：Level C ；推荐强度：Class Ⅰ）
[znzldj] => A
[_inputtime] => 1704957181
[_updatetime] => 1704957181
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果时间允许，推荐在非心脏手术前优化指南推荐的心血管疾病治疗和心血管危险因素控制。（证据级别：Level C ；推荐强度：Class Ⅰ）
If time allows, it is recommended to optimize guideline-recommended treatment of CVD and CV risk factors before NCS. (Evidence: Level C，Recommendation: Class Ⅰ)
证据评价方法：LOE
指南质量等级：A
年份：2022
国家：European Society of Cardiology
